[Expression of melanoma-associated antigen-C2 in breast cancers and mechanism].

Li, N; Hou, R; Zhao, L M; Gu, G; Hou, S Y

Li, N; Hou, R; Zhao, L M; Gu, G; Hou, S Y.

Afiliação

Li N; Department of Oncology, the Third Hospital of Hebei Medical University, Shijiazhuang 050051, China.
Hou R; Department of Oncology, the Fourth Hospital of Hebei Medical University, Shijiazhuang 050019, China.
Zhao LM; Department of Research Center, the Fourth Hospital of Hebei Medical University, Shijiazhuang 050019, China.
Gu G; Department of Rheumatology and Immunology, the Third Hospital of Hebei Medical University, Shijiazhuang 050051, China.
Hou SY; Department of Rheumatology and Immunology, the Third Hospital of Hebei Medical University, Shijiazhuang 050051, China.

Zhonghua Zhong Liu Za Zhi ; 43(8): 821-826, 2021 Aug 23.

Article em Zh | MEDLINE | ID: mdl-34407585

Assuntos

Neoplasias da Mama; Melanoma; Azacitidina/farmacologia; Neoplasias da Mama/genética; Decitabina/farmacologia; Feminino; Inibidores de Histona Desacetilases/farmacologia; Humanos

Palavras-chave

5-aza-2'-deoxycytidine; Breast neoplasms; Melanoma-associated antigen-C2; Trichostatin A

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Pele Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Melanoma Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: Zh Revista: Zhonghua Zhong Liu Za Zhi Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google